1. Home
  2. TK vs IVA Comparison

TK vs IVA Comparison

Compare TK & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$9.18

Market Cap

796.4M

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.22

Market Cap

769.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
IVA
Founded
1973
2011
Country
Bermuda
France
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
796.4M
769.0M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TK
IVA
Price
$9.18
$4.22
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$17.14
AVG Volume (30 Days)
604.1K
214.2K
Earning Date
10-29-2025
09-29-2025
Dividend Yield
21.23%
N/A
EPS Growth
N/A
N/A
EPS
0.88
N/A
Revenue
$992,518,000.00
$19,929,536.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.65
$2.11
52 Week High
$10.60
$7.98

Technical Indicators

Market Signals
Indicator
TK
IVA
Relative Strength Index (RSI) 43.54 45.69
Support Level $9.11 $4.32
Resistance Level $9.43 $4.71
Average True Range (ATR) 0.24 0.23
MACD -0.06 0.03
Stochastic Oscillator 13.48 28.77

Price Performance

Historical Comparison
TK
IVA

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: